Antibody functionalized magnetic nanoparticles for circulating tumor cells detection and capture using magnetophoresis

5Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Circulating tumor cells (CTCs) are cells present in the blood stream during the metastasis process. They can originate from primary or secondary tumors. Circulating tumor cells can be used for early diagnosis or they can be used for prognosis evaluation and even treatment efficiency evaluation. Circulating tumor cells can be captured based on specific antigens found on their surface that differ from those of normal blood cells, they can be captured using specific electrical signatures using dielectrophoresis and they can also be captured using induced magnetic properties and magnetophoresis. In this paper we describe a method for synthesizing and functionalizing superparamagnetic nanoparticles. The nanoparticles will be covered with polyethylenglicol (PEG) molecules to reduce agglomeration and non-specific cell adhesion or blood proteins fouling. The PEG covered magnetic nanoparticles will be functionalized with anti-EpCAM antibodies that are going to make the nanoparticles specifically bind to CTCs present in the blood sample. The samples will be further processed in a microfluidic device that will separate the targeted cells through magnetophoresis.

Cite

CITATION STYLE

APA

Burinaru, T. A., Volmer, M., Avram, M., Ucureanu, V., Avram, A., Incu, B., … Militaru, M. (2019). Antibody functionalized magnetic nanoparticles for circulating tumor cells detection and capture using magnetophoresis. In IOP Conference Series: Materials Science and Engineering (Vol. 485). Institute of Physics Publishing. https://doi.org/10.1088/1757-899X/485/1/012005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free